Cannabis stocks surged after Trump endorsed CBD for senior healthcare, citing its potential to revolutionize treatment and reduce healthcare costs. Shares of TLRY, CGC, CRON, and ACB soared double dig
Video posted on Truth Social touts CBD as a ‘gamechanger' and promotes Medicaid coverage of CBD products
Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%.
The Canadian cannabis sector remains a focus for investors as September trading continues. Market leaders are working to expand operations while positioning for long-term growth. Meanwhile, the U.S. c

3 Marijuana Stocks For Better Gains This Month

10:18am, Friday, 12'th Sep 2025
What is it about legal cannabis that keeps marijuana stock investors holding the bag? By this I mean the beating the sector has taken over the last few years. Cannabis stocks are unlike other sectors,
Cronos trades near its 52-week high as international growth boosts sales, but losses and stiff competition weigh on its outlook.
The cannabis industry continues to demonstrate why it deserves the same opportunities as other legitimate businesses. From an investment side, there are many who have put up big money in various globa
Bitcoin, Ethereum and other cryptocurrencies were reacting to hopes of interest-rate cuts while President Donald Trump's family is backing smaller crypto Cronos.
Investors are closely watching the US cannabis space after President Donald Trump signaled plans to reschedule marijuana, a move that is expected to unlock near-term financial relief and longer-term
In the last 3-6 months, most marijuana stocks have gone from bottom prices to an upward swing. For a long while, the sector has fallen and lain dormant. This led to much fear and doubt among some shar
Marijuana stocks have begun to gain traction in trading, exhibiting moderate consistency. But why did this occur, and what is happening to bring such momentum to the sector? Once again, the backing an
Cannabis stocks rallied today over news of possible rescheduling by the Trump administration. Even though Cronos Group Inc. does not have a U.S. entry strategy, its stock price was up 15% on the news.
Cannabis stocks moved sharply higher on reports that President Donald Trump is considering rescheduling marijuana to a less restrictive drug category. The move would see marijuana reclassified from a
Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level. Canopy Growth an
Cronos Group Inc. (NASDAQ:CRON ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Anna Shlimak - Chief Financial Officer Harrison Aaron - Corporate Participant Michael R
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE